Please provide your email address to receive an email when new articles are posted on . Direct-to-consumer germline testing for cancer predisposition without oversight and guidance can cause anxiety, ...

Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care Although ...

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking ...

In the era of precision medicine, genomic interrogation for identification of both germline and somatic genetic alterations has become increasingly important. While such germline testing was usually ...

A new editorial was published in Oncotarget's Volume 15 on December 24, 2024, titled "Pitfalls and perils from FDA-approved germ-line cancer predisposition tests." Authored by Dr. Wafik S. El-Deiry, ...

Let's say someone in your family has had cancer. Maybe it was even you. How could you find out if the cancer is hereditary and if other members of your family could be at increased risk? The answer?

SILVER SPRING, Md., Sept. 29, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration granted de novo marketing authorization for the Invitae Common Hereditary Cancers Panel, an in vitro ...

Dear Dr. Gott: While watching the news, I heard about a test kit I can purchase over the counter that will indicate a possible genetic predisposition to such medical problems as Parkinson's disease ...